[ad_1] Get instant alerts when news breaks on your actions. Claim your free two week trial at StreetInsider Premium here (Reuters) – Drug maker Merck & Co (NYSE: MRK) has increased its …
Read More »Merck's profit beats Keytruda's strength, increases forecasts for the year
